KM Financial Solutions | Blues health insurers fund U.S. non-profit’s generic drug expansion
62571
post-template-default,single,single-post,postid-62571,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Blues health insurers fund U.S. non-profit’s generic drug expansion

Blues health insurers fund U.S. non-profit’s generic drug expansion

A group of Blue Cross Blue
Shield insurers is investing $55 million in a new venture with a
non-profit generic drug manufacturer to try to offer cheaper
prices on pharmacy drugs to their members, the companies said on
Thursday.

No Comments

Sorry, the comment form is closed at this time.